Marshall Wace’s Genomic Health, Inc. GHDX Stock Holding History

Marshall Wace’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,468	Closed	-$506K	–	2282
2019 Q3	$506K	Sell	7,468 -56,016	-88%	-$3.85M	﹤0.01%	1108
2019 Q2	$3.69M	Buy	+63,484	New	+$3.76M	0.03%	582
2016 Q3	–	Sell	-42,896	Closed	-$1.11M	–	1221
2016 Q2	$1.11M	Sell	42,896 -703	-2%	-$18.7K	0.01%	699
2016 Q1	$1.08M	Sell	43,599 -129,620	-75%	-$3.56M	0.01%	694
2015 Q4	$6.1M	Buy	+173,219	New	+$4.64M	0.06%	336

Marshall Wace's GHDX Position: Q4 2019 in Review

Marshall Wace sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 7,468 shares — an estimated $506K sold.

Marshall Wace first reported a position in GHDX in Q4 2015 and held it in 5 quarters. The position peaked at $6.1M in Q4 2015. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Marshall Wace reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Marshall Wace sold 7,468 Genomic Health, Inc. shares in Q4 2019, an estimated $506K.
Marshall Wace first reported a position in Genomic Health, Inc. in Q4 2015 and held it in 5 quarters.
Marshall Wace's Genomic Health, Inc. position peaked at $6.1M in Q4 2015.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Marshall Wace's 13F filing for Q4 2019, filed 14 Feb 2020.